Table 3.

The MetS risk across quartiles of atherogenic indices

	Male				Female
	Model 1 OR (95% CI)	P value	Model 2 OR (95% CI)	P value	Model 1 OR (95% CI)	P value	Model 2 OR (95% CI)	P value
AIP
Q1; < − 0.08	1 (Reference)		1 (Reference		1 (Reference)		1 (Reference
Q2; − 0.08–0.09	1.83 (1.34–2.50)	< 0.001	1.41 (0.99–1.98)	0.051	2.79 (2.39–3.26)	< 0.001	2.50 (2.12–2.95)	< 0.001
Q3; 0.09–0.27	5.76 (4.34–7.64)	< 0.001	4.78 (3.49–6.56)	< 0.001	12.56 (10.6–14.89)	< 0.001	11.78 (9.84–14.11)	< 0.001
Q4; > 0.27	15.21 (11.54–20.06)	< 0.001	14.63 (10.66–20.07)	< 0.001	77.14 (57.48–103.52)	< 0.001	77.56 (57.17–105.24)	< 0.001
TC/HDL-c
Q1; < 3.21	1 (Reference)		1 (Reference)		1 (Reference)		1 (Reference)
Q2; 3.21–3.81	1.36 (1.04–1.74)	0.014	1.26 (0.95–1.67)	0.1	2.03 (1.76–2.34)	< 0.001	1.86 (1.60–2.17)	< 0.001
Q3; 3.81–4.49	2.26 (1.79–2.84)	< 0.001	1.89 (1.46–2.46)	< 0.001	4.64 (3.99–5.40)	< 0.001	4.13 (3.52–4.85)	< 0.001
Q4; > 4.49	4.93 (3.95–6.14)	< 0.001	4.34 (3.37–5.60)	< 0.001	14.27 (11.73–17.37)	< 0.001	12.77 (10.39–15.67)	< 0.001
LDL-c/HDL-c
Q1; < 1.69	1 (Reference)		1 (Reference)		1 (Reference)		1 (Reference)
Q2; 1.69–2.15	1.05 (0.86–1. 29)	0.60	0.99 (0.78–1.25)	0.91	1.31 (1.14–1.51)	< 0.001	1.23 (1.06–1.43)	0.006
Q3; 2.15-.2.64	1.04 (0.85–1.27)	0.65	0.91 (0.72–1.15)	0.43	2.28 (1.97–2.64)	< 0.001	2.02 (1.73–2.36)	< 0.001
Q4; > 2.64	1.62 (1.34–1.96)	< 0.001	1.33 (1.07–1.65)	0.01	3.89 (3.32–4.57)	< 0.001	3.28 (2.75–3.86)	< 0.001
Non-HDL-c
Q1; < 2.92	1 (Reference)		1 (Reference)		1 (Reference)		1 (Reference)
Q2; 2.92–3.51	1.17 (0.96–1.42)	0.112	0.99 (0.79–1.25)	0.99	1.37 (1.18–1.59)	< 0.001	1.28 (1.09–1.50)	0.002
Q3; 3.51–4.16	1.51 (1.25–1.83)	< 0.001	1.18 (0.95–1.47)	0.13	2.10 (1.81–2.43)	< 0.001	1.77 (1.51–2.07)	< 0.001
Q4; > 4.16	1.98 (1.64–2.38)	< 0.001	1.48 (1.19–1.84)	< 0.001	3.51 (3.01–4.09)	< 0.001	2.64 (2.24–3.11)	< 0.001
TyG
Q1; < 8.47	1 (Reference)		1 (Reference)		1 (Reference)		1 (Reference)
Q2; 8.47–8.85	2.99 (2.16–4.14)	< 0.001	2.05 (1.45–2.91)	< 0.001	2.54 (2.14–3)	< 0.001	2.06 (1.73–2.45)	< 0.001
Q3; 8.85–9.30	10.31 (7.59–14.01)	< 0.001	7.54 (5.40–10.51)	< 0.001	15.40 (12.91–18.36)	< 0.001	12.63 (10.54–15.14)	< 0.001
Q4; > 9.30	26.12 (19.23–35.47)	< 0.001	20.74 (14.83–29)	< 0.001	64.73 (50.31–82.86)	< 0.001	52.47 (40.48–68.02)	< 0.001

Model 1: crude model. Model 2: adjusted for age, BMI, physical activity, energy intake, and smoking

AIP atherogenic index of plasma, TC total cholesterol, HDL-c high-density lipoprotein cholesterol, LDL-c low-density lipoprotein cholesterol, TyG index triglyceride-glucose, CI confidence interval, OR odds ratio